Clinical Trial Update: Phase II Trial of RC1416 Injection in Asthma [Phase 2]

View source ↗

Summary

Phase II trial of RC1416 Injection for asthma is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• RC1416 Injection

Snippet

Sponsor: Nanjing RegeneCore Biotech Co., Ltd. | Conditions: Moderate to Severe Asthma | Phase 2 | Status: NOT_YET_RECRUITING